[The Bell] ITCen PNS signs MOU to drive shift in security paradigm
Predicted impact: Low· Actual: −17.5% vs sector, volume 0.1× normal (5 trading days)
Security MOU signed; no contract value or financial size disclosed.
232830 · KOSDAQ · ₩232830 · 아이티센피엔에스
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−62.1% from the high
₩1,211Today: ₩2,025 – ₩2,220₩5,590
Returns
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals describe activity, not recommendations. Not financial advice.
Itcenpns (아이티센피엔에스, KRX: 232830) is listed on KOSDAQ, in the Software sector. ) is a security platform company founded in 2011 that develops security and biometric authentication solutions, including electronic signature technology based on fingerprint, face and vein biometrics, mobile app security products, and digital banking and financial compliance system development. Its shares closed at ₩2,120 on Oct 26, 2026, up 1.92% on the day, giving it a market value of ₩35B.
IT Center PNS (IT-Center PNS Co., Ltd.) is a security platform company founded in 2011 that develops security and biometric authentication solutions, including electronic signature technology based on fingerprint, face and vein biometrics, mobile app security products, and digital banking and financial compliance system development. It also distributes global cybersecurity products such as Palo Alto Networks and CyberArk in Korea and serves banks, insurers, card companies, financial groups and government agencies, with two unlisted subsidiaries handling IT hardware distribution and total IT services.
Written by AI from the company's latest annual report.
Predicted impact: Low· Actual: −17.5% vs sector, volume 0.1× normal (5 trading days)
Security MOU signed; no contract value or financial size disclosed.
Titles in Korean until English translations are added.
Also known as: Itcenpns / 아이티센피엔에스 / 232830 / KRX:232830
Source: KRX statistical information